FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum
SUVEN Share Price Target
Suven Life Sciences Ltd.
Sector: Pharmaceuticals and health care
Sector: Pharmaceuticals and health care
SUVEN Long Term Analysts Rating
- ★★
- ★★
- ★★
- ★★
- ★★
4.7/5 (7 Ratings)
SUVEN Share Price *
301.45 +0 (0%)
* (quote may be delayed)
7 SUVEN share price target reports by brokerages below. See what is analyst's view on SUVEN share price forecast, rating, estimates, valuation and prediction behind the target. You may use these research report forecasts for long-term to medium term for your investment or trades in 2020.
You can also find SUVEN share price target tomorrow or next week from SUVEN discussion forum.
SUVEN Share Price Forecast - Consensus
| No. of reports in last year | 7 |
| No. of analysts | 4 |
| Average Consensus Forecast | 318.00 |
| Consensus Potential | 3.72% |
SUVEN Share Price Target - Broker Reports - 2019
Kotak Securities
3-Dec-19
Price @ Call: 273.67
Target: 391
BUY
As mentioned in our report dated November 21, 2019, the total NCE value assigned was Rs 76, of which Rs 54 was from SUVN-502. Post the failure of SUVN 502, we have deduced this amount as the potential of out-licensing is out of picture. Thus we arrive at our revised target price of Rs 391 (vs. earlier target price of Rs 445), valuing the stock at 19x FY22E EPS of Rs.19.4 arriving at price of Rs.369 (for base business). We have added the value of other 3 molecules put together at Rs 22.
Geojit Financial Services
21-Nov-19
Price @ Call: 299.39
Target: 360
BUY
We also improve the PAT estimates by 17%/13% for FY20/21 and retain the ‘Buy’ rating on a multiple of 20x on FY21E EPS with a revised TP of Rs 360.
Geojit Financial Services
27-Aug-19
Price @ Call: 253.75
Target: 303
BUY
Suven is currently trading at a 1 year forward P/E of 16x. Considering the improving operational efficiency we foresee stable EBITDA margin to remain higher and forecast PAT to grow at 17% each for both FY20 and FY21. We upgrade the rating to ‘Buy’ from ‘Hold’ on a multiple of 18x with a revised target price of Rs 303.
AnandRathi
26-Aug-19
Price @ Call: 254.96
Target: 300
BUY
Geojit Financial Services
29-May-19
Price @ Call: 266.55
Target: 297
HOLD
We forecast sales and PAT to grow at a CAGR of 12% and 11% resp. (FY19-21E) and increase revenue estimate by ~4%&5% resp. for FY20/21. Considering the low momentum in sales & PAT growth we downgrade the rating to ‘Hold’ from‘Buy’ on a multiple of 20x with a revised target price of Rs291.
Dolat Capital
8-Feb-19
Price @ Call: 233.41
Target: 315
BUY
Geojit Financial Services
7-Feb-19
Price @ Call: 220.3
Target: 260
BUY
SUVEN Share Price Target - Broker Reports - 2018
ICICIdirect.com
10-Oct-18
Price @ Call: 243.55
Target: 315
BUY
Arihant Capital Markets
3-Sep-18
Price @ Call: 279.05
Target: 325
ACCUMULATE
- keyboard_arrow_down
SUVEN Peer Stocks - Share Price Targets
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.